Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Michon

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Pathology|September 22, 2009
Cholinergic switch associated with morphological differentiation in neuroblastomaFranck Bourdeaut, Isabelle Janoueix-Lerosey, Carlo Lucchesi, et al.
Pediatric Blood & Cancer|September 2, 2014
Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'EnfantSarah Cohen-Gogo, Cécile Cellier, Jean-Michel Coindre, et al.
JCO Oncology Practice|June 17, 2020
Relationships Between Managerial and Organizational Practices, Psychological Health at Work, and Quality of Care in Pediatric OncologyJulien Lejeune, Severine Chevalier, Evelyne Fouquereau, et al.
International Journal of Cancer|October 3, 2006
Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control studySylvie Guérin, Catherine Guibout, Akthar Shamsaldin, et al.
Pediatric Blood & Cancer|March 31, 2015
Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resectionSabine Irtan, Hervé J Brisse, Véronique Minard-Colin, et al.
Mabs|August 9, 2013
Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 studyRuth Ladenstein, Silke Weixler, Bianca Baykan, et al.
Journal of Pediatric Hematology/Oncology|November 15, 2017
Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus SyndromeBarbara Hero, Nathalie Clement, Ingrid Øra, et al.
Cancer|May 17, 2002
Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter studyFrederique Sauvat, Sabine Sarnacki, Herve Brisse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocolDominique Valteau-Couanet, Jean Michon, Andrée Boneu, et al.
Pediatric Blood & Cancer|April 13, 2006
Role of chemotherapy resistance genes in outcome of neuroblastomaPatricia de Cremoux, Nathalie Jourdan-Da-Silva, Jérôme Couturier, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Pathology|September 22, 2009
Cholinergic switch associated with morphological differentiation in neuroblastomaFranck Bourdeaut, Isabelle Janoueix-Lerosey, Carlo Lucchesi, et al.
Pediatric Blood & Cancer|September 2, 2014
Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L'EnfantSarah Cohen-Gogo, Cécile Cellier, Jean-Michel Coindre, et al.
JCO Oncology Practice|June 17, 2020
Relationships Between Managerial and Organizational Practices, Psychological Health at Work, and Quality of Care in Pediatric OncologyJulien Lejeune, Severine Chevalier, Evelyne Fouquereau, et al.
International Journal of Cancer|October 3, 2006
Concomitant chemo-radiotherapy and local dose of radiation as risk factors for second malignant neoplasms after solid cancer in childhood: a case-control studySylvie Guérin, Catherine Guibout, Akthar Shamsaldin, et al.
Pediatric Blood & Cancer|March 31, 2015
Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resectionSabine Irtan, Hervé J Brisse, Véronique Minard-Colin, et al.
Mabs|August 9, 2013
Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: a SIOPEN Phase 1 studyRuth Ladenstein, Silke Weixler, Bianca Baykan, et al.
Journal of Pediatric Hematology/Oncology|November 15, 2017
Genomic Profiles of Neuroblastoma Associated With Opsoclonus Myoclonus SyndromeBarbara Hero, Nathalie Clement, Ingrid Øra, et al.
Cancer|May 17, 2002
Outcome of suprarenal localized masses diagnosed during the perinatal period: a retrospective multicenter studyFrederique Sauvat, Sabine Sarnacki, Herve Brisse, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Results of induction chemotherapy in children older than 1 year with a stage 4 neuroblastoma treated with the NB 97 French Society of Pediatric Oncology (SFOP) protocolDominique Valteau-Couanet, Jean Michon, Andrée Boneu, et al.
Pediatric Blood & Cancer|April 13, 2006
Role of chemotherapy resistance genes in outcome of neuroblastomaPatricia de Cremoux, Nathalie Jourdan-Da-Silva, Jérôme Couturier, et al.
Pageof 11